HP_A_217569 53..63

Nathan W Sweeney Cecil J Gomes Richard De Armond Sara M Centuori 3 Sairam Parthasarathy Jesse D Martinez 1Cancer Biology Graduate Interdisciplinary Program, University of Arizona, Tucson, AZ, USA; 2University of Arizona Health Sciences Center for Sleep and Circadian Sciences, Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, Department of Medicine, University of Arizona, Tucson, AZ, USA; 3University of Arizona Cancer Center, University of Arizona, Tucson, AZ, USA; 4Department of Cellular and Molecular Medicine, Cell and Molecular Medicine, University of Arizona, Tucson, AZ, USA Purpose: Nonalcoholic fatty liver disease (NAFLD) is considered the most common form of silent liver disease in the United States and obesity is associated with increased risk of NAFLD. Obstructive sleep apnea (OSA) which is common in obese individuals is associated with a greater incidence of NAFLD, which in turn, increases the risk for hepatocellular carcinoma (HCC). It is unclear how obesity, OSA and NAFLD interrelate nor how they collectively contribute to an increased risk for developing HCC. Patients and methods: Male BALB/c mice were exposed to diethylnitrosamine and phenobarbital followed by 48 weeks of either standard chow diet (chow), chow with hypoxia, high-fat diet, or a combination of hypoxia and high-fat diet. We noninvasively monitored tumor development using micro-CT imaging. We tracked the total weight gained throughout the study. We evaluated liver histology, fat accumulation, carbonic anhydrase 9 (CA9) and hypoxia-inducible factor 1-alpha (HIF-1α) expression, as well as, serum aspartate aminotransferase (AST) and alanine aminotransferase (ALT). Results: A high-fat diet without hypoxia led to the development of obesity that induced hepatic steatosis and promoted tumorigenesis. Animals on a high-fat diet and that were also exposed to hypoxia had lower total weight gain, lower steatosis, lower serum AST and ALT levels, and fewer number of hepatic adenomas than a high-fat diet without hypoxia. Conclusion: These findings suggest that hypoxia abrogates obesity, hepatic steatosis, and hepatic tumorigenesis related to a high-fat diet.

[1]  Yihai Cao Adipocyte and lipid metabolism in cancer drug resistance. , 2019, The Journal of clinical investigation.

[2]  Stephen Marchant,et al.  Intraperitoneal injections as an alternative method for micro-CT contrast enhanced detection of murine liver tumors. , 2019, BioTechniques.

[3]  Yihai Cao,et al.  Cancer Lipid Metabolism Confers Antiangiogenic Drug Resistance. , 2018, Cell metabolism.

[4]  A. Kraft,et al.  Hypoxia-Inducible PIM Kinase Expression Promotes Resistance to Antiangiogenic Agents , 2017, Clinical Cancer Research.

[5]  C. Cho,et al.  Accelerated tumor growth under intermittent hypoxia is associated with hypoxia-inducible factor-1-dependent adaptive responses to hypoxia. , 2017, Oncotarget.

[6]  V. Polotsky,et al.  Hepatocyte Hypoxia Inducible Factor-1 Mediates the Development of Liver Fibrosis in a Mouse Model of Nonalcoholic Fatty Liver Disease , 2016, PloS one.

[7]  L. Adams,et al.  International Journal of Molecular Sciences the Natural Course of Non-alcoholic Fatty Liver Disease , 2022 .

[8]  Hypoxia-inducible factors as molecular targets for liver diseases , 2016, Journal of Molecular Medicine.

[9]  Ahmedin Jemal,et al.  Global Cancer Incidence and Mortality Rates and Trends—An Update , 2015, Cancer Epidemiology, Biomarkers & Prevention.

[10]  A. Malhotra,et al.  Obstructive Sleep Apnea Is Associated with Nonalcoholic Steatohepatitis and Advanced Liver Histology , 2015, Digestive Diseases and Sciences.

[11]  I. Benseñor,et al.  Effects of CPAP on body weight in patients with obstructive sleep apnoea: a meta-analysis of randomised trials , 2014, Thorax.

[12]  S. Shinjo,et al.  Hypoxia and fatty liver. , 2014, World journal of gastroenterology.

[13]  D. Clegg,et al.  Ascent to altitude as a weight loss method: The good and bad of hypoxia inducible factor activation , 2014, Obesity.

[14]  R. Farré,et al.  Association between obstructive sleep apnea and cancer incidence in a large multicenter Spanish cohort. , 2013, American journal of respiratory and critical care medicine.

[15]  S. Bhanot,et al.  Metabolic Consequences of High-Fat Diet Are Attenuated by Suppression of HIF-1α , 2012, PloS one.

[16]  B. Krock,et al.  Hypoxia-induced angiogenesis: good and evil. , 2011, Genes & cancer.

[17]  竹原 徹郎,et al.  Liver, Pancreas, and Biliary Tract ヒト化マウスモデルを用いたC型肝炎ウイルスによる感染、免疫応答、肝病態形成の解析 , 2011 .

[18]  Jianguo Li,et al.  Intermittent Hypoxia Exacerbates Metabolic Effects of Diet‐Induced Obesity , 2011, Obesity.

[19]  K. Basen-Engquist,et al.  Obesity and Cancer Risk: Recent Review and Evidence , 2011, Current oncology reports.

[20]  J. Ward,et al.  Proliferative and Nonproliferative Lesions of the Rat and Mouse Hepatobiliary System , 2010, Toxicologic pathology.

[21]  Rainald Fischer,et al.  Hypobaric Hypoxia Causes Body Weight Reduction in Obese Subjects , 2010, Obesity.

[22]  S. Klein,et al.  Obesity and nonalcoholic fatty liver disease: Biochemical, metabolic, and clinical implications , 2010, Hepatology.

[23]  A. Feldstein,et al.  Lipotoxicity in nonalcoholic fatty liver disease: not all lipids are created equal , 2009, Expert review of gastroenterology & hepatology.

[24]  M. Kryger,et al.  Epidemiology of obstructive sleep apnea: a population-based perspective , 2008, Expert review of respiratory medicine.

[25]  Geng-Wen Huang,et al.  Expression of hypoxia-inducible factor 1alpha and vascular endothelial growth factor in hepatocellular carcinoma: Impact on neovascularization and survival. , 2005 .

[26]  Michael J Thun,et al.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. , 2003, The New England journal of medicine.

[27]  Johan Bussink,et al.  Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer. , 2002, Cancer research.

[28]  M. Lerman,et al.  Carbonic anhydrase 9 as an endogenous marker for hypoxic cells in cervical cancer. , 2001, Cancer research.

[29]  J. Dixon,et al.  Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. , 2001, Gastroenterology.

[30]  C. Weghorst,et al.  Dose-Response Relationship of Diethylnitrosamine-Initiated Tumors in Neonatal Balb/c Mice: Effect of Phenobarbital Promotion , 1988, Toxicologic pathology.